Rubicon Research IPO opened on October 9, 2025. The subscription closed on October 13, 2025. The listing is scheduled for October 16, 2025.
Rubicon Research Limited is a pharma company based in India. It was founded in 1999. The company develops and manufactures special drug formulations. It also sells these products in the U.S. and other global markets. As of June 2025, Rubicon had 72 approved drug products by the U.S. FDA. It also had 17 new products…